Braidwell LP Rapt Therapeutics, Inc. Transaction History

Braidwell LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$11.28 - $25.46 $7.82 Million - $17.6 Million	-693,212 Reduced 64.04%	389,300 $9.67 Billion
Q3 2023 Nov 14, 2023	BUY	$16.34 - $24.66 $1.6 Million - $2.42 Million	98,112 Added 9.97%	1,082,512 $18 Billion
Q2 2023 Aug 14, 2023	BUY	$16.06 - $21.61 $15.8 Million - $21.3 Million	984,400 New	984,400 $18.4 Billion
Q4 2022 Feb 14, 2023	BUY	$16.28 - $24.6 $16.3 Million - $24.6 Million	1,000,000 New	1,000,000 $19.8 Billion

104

49.4M

26.7K

2.4K

Ticker RAPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,656,600
Market Cap $34.7M
Description
RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovering, developing, and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. Its lead inflammation drug candidate is RPT193, a C-C motif chemokine receptor 4 (CCR4) antagonist that se...

Get notified when there are updates to the investment portfolio of Braidwell LP, based on Form 13F filings with the SEC.

Stay updated on Braidwell LP with notifications on news.